You can find the annual or quarterly income statement of 4D Molecular Therapeutics Inc here for insights into the performance and operational efficiency of 4D Molecular Therapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2019Q4

FY2019Q3

Total revenue

2900.00%90.00K

200.00%15.00K

-50.00%14.00K

--1.00K

-99.99%3.00K

-97.91%5.00K

-90.60%28.00K

3940.80%20.20M

47.53%239.00K

-75.55%298.00K

1255.43%1.25M

-63.40%500.00K

-98.89%162.00K

-39.05%1.22M

--92.00K

--1.37M

--14.58M

--2.00M

--2.03M

--540.00K

Revenue

2900.00%90.00K

200.00%15.00K

-50.00%14.00K

--1.00K

-99.99%3.00K

-97.91%5.00K

-90.60%28.00K

3940.80%20.20M

47.53%239.00K

-75.55%298.00K

1255.43%1.25M

-63.40%500.00K

-98.89%162.00K

-39.05%1.22M

--92.00K

--1.37M

--14.58M

--2.00M

--2.03M

--540.00K

Operating expenses

19.83%61.27M

40.06%59.47M

40.54%53.63M

--56.12M

49.61%51.13M

31.15%42.46M

25.52%38.16M

26.61%34.18M

13.25%32.38M

10.12%30.40M

20.56%29.97M

12.35%27.00M

28.91%28.59M

50.78%27.61M

--24.86M

--24.03M

--22.18M

--18.31M

--18.32M

--12.43M

R&D expenses

28.46%49.44M

50.51%47.95M

46.03%40.70M

--43.09M

53.53%38.48M

35.09%31.86M

24.35%27.87M

32.34%25.07M

15.48%23.58M

15.64%22.41M

22.66%21.50M

19.57%18.94M

34.15%20.42M

51.78%19.38M

--17.53M

--15.84M

--15.22M

--12.77M

--12.36M

--9.37M

Depreciation, depletion, and amortization

-23.66%1.30M

-19.95%1.30M

10.04%1.75M

--1.78M

21.99%1.70M

13.73%1.62M

12.89%1.59M

58.82%1.40M

71.84%1.43M

80.56%1.41M

-26.44%1.39M

130.10%879.00K

124.59%831.00K

105.25%782.00K

--1.89M

--382.00K

--370.00K

--381.00K

--318.00K

--300.00K

Operating profit

-19.66%-61.19M

-40.04%-59.46M

-40.60%-53.62M

---56.12M

-265.91%-51.13M

-32.11%-42.46M

-26.67%-38.14M

47.26%-13.97M

-13.05%-32.14M

-14.07%-30.11M

-15.97%-28.72M

-16.92%-26.50M

-274.22%-28.43M

-61.79%-26.39M

---24.76M

---22.66M

---7.60M

---16.31M

---16.29M

---11.89M

Net non-operating interest income (expenses)

Non-operating interest income

-40.60%4.33M

-35.63%4.86M

-2.84%5.58M

--6.47M

88.08%7.29M

200.48%7.55M

298.13%5.75M

387.55%3.88M

638.82%2.51M

1343.00%1.44M

--1.34M

82.76%795.00K

4757.14%340.00K

1328.57%100.00K

----

--435.00K

--7.00K

--218.00K

--341.00K

Special income (expenses)

----

--0.00

---5.14M

Other non-operating income (expenses)

-2000.00%-21.00K

-35.56%-61.00K

770.00%67.00K

---21.00K

99.37%-1.00K

-662.50%-45.00K

47.37%-10.00K

-1855.56%-158.00K

--8.00K

58.70%-19.00K

142.86%3.00K

169.23%9.00K

--0.00

54.46%-46.00K

---7.00K

---13.00K

--0.00

---101.00K

---45.00K

--7.00K

Income before tax

-29.73%-56.88M

-56.38%-54.66M

-48.06%-47.97M

---49.67M

-327.49%-43.84M

-18.02%-34.95M

-12.97%-32.40M

60.08%-10.26M

-5.45%-29.62M

-8.90%-28.68M

-9.15%-27.38M

-15.52%-25.69M

-270.09%-28.09M

-60.54%-26.34M

---25.08M

---22.24M

---7.59M

---16.41M

---16.11M

---16.68M

Income tax

----

--0.00

----

Income after tax

-29.73%-56.88M

-56.38%-54.66M

-48.06%-47.97M

---49.67M

-327.49%-43.84M

-18.02%-34.95M

-12.97%-32.40M

60.08%-10.26M

-5.45%-29.62M

-8.90%-28.68M

-9.15%-27.38M

-15.52%-25.69M

-270.09%-28.09M

-60.54%-26.34M

---25.08M

---22.24M

---7.59M

---16.41M

---16.11M

---16.68M

Net income from continuous operations

-29.73%-56.88M

-56.38%-54.66M

-48.06%-47.97M

---49.67M

-327.49%-43.84M

-18.02%-34.95M

-12.97%-32.40M

60.08%-10.26M

-5.45%-29.62M

-8.90%-28.68M

-9.15%-27.38M

-15.52%-25.69M

-270.09%-28.09M

-60.54%-26.34M

---25.08M

---22.24M

---7.59M

---16.41M

---16.11M

---16.68M

Net income attributable to controlling interests

-29.73%-56.88M

-56.38%-54.66M

-48.06%-47.97M

---49.67M

-327.49%-43.84M

-18.02%-34.95M

-12.97%-32.40M

60.08%-10.26M

-5.45%-29.62M

-8.90%-28.68M

-9.15%-27.38M

-15.52%-25.69M

-270.09%-28.09M

-60.54%-26.34M

---25.08M

---22.24M

---7.59M

---16.41M

---16.11M

---16.68M

Net income attributable to common shareholders

-29.73%-56.88M

-56.38%-54.66M

-48.06%-47.97M

---49.67M

-327.49%-43.84M

-18.02%-34.95M

-12.97%-32.40M

60.08%-10.26M

-5.45%-29.62M

-8.90%-28.68M

-9.15%-27.38M

-15.52%-25.69M

-270.09%-28.09M

-60.54%-26.34M

---25.08M

---22.24M

---7.59M

---16.41M

---16.11M

---16.68M

Basic earnings per share

-28.41%-1.01

-54.57%-0.98

-30.87%-0.86

---0.89

-225.16%-0.79

18.16%-0.63

24.97%-0.66

69.40%-0.24

11.09%-0.77

-7.26%-0.88

-2.36%-0.84

3.61%-0.79

-206.14%-0.87

-32.94%-0.82

---0.82

---0.28

---0.61

---3.06

---3.17

Diluted earnings per share

-28.41%-1.01

-54.57%-0.98

-30.87%-0.86

---0.89

-225.16%-0.79

18.16%-0.63

24.97%-0.66

69.40%-0.24

11.09%-0.77

-7.26%-0.88

-2.36%-0.84

3.61%-0.79

-206.14%-0.87

-32.94%-0.82

---0.82

---0.28

---0.61

---3.06

---3.17

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

